These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6949460)

  • 1. Haemodynamic effects of prazosin in CHF.
    Reuben SR; Kuan P; Gale EV; Wilde PM
    Acta Med Scand Suppl; 1981; 652():145-8. PubMed ID: 6949460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetic, pharmacodynamic and haemodynamic effects of acute and chronic alpha-adrenoceptor blockade in chronic heart failure.
    Taylor SH; Silke B
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):45-51. PubMed ID: 6124209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
    Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
    Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L; Foster PR; Friedman AW; Statza J; McHenry PL
    Br Heart J; 1981 Feb; 45(2):186-92. PubMed ID: 7459177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
    Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O; Burkart F; Bühler FR
    Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sustained and beneficial hemodynamic effects of prazosin in cardiac insufficiency].
    Harrison DC; Feldman RC; Ball RM
    Cardiology; 1980; 66 Suppl 2():162-8. PubMed ID: 6456814
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
    Mehta J; Feldman RL; Nichols WW; Pepine CJ; Conti CR
    Br Heart J; 1980 May; 43(5):556-60. PubMed ID: 7378216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
    Nakajima H; Yui Y; Kawashita K; Yoshida A; Kawai C
    Jpn Circ J; 1982 May; 46(5):468-72. PubMed ID: 7077811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the vasodilator prazosin and the selective beta1 agonist prenalterol on rest and exercise haemodynamics in CHF.
    Hutton I; Tweddel AC; Bastian BC; Murray RG
    Acta Med Scand Suppl; 1981; 652():163-8. PubMed ID: 6120615
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prazosin long-term treatment in severe chronic cardiac failure (author's transl)].
    Kuck KH; Hanrath P; Zehnke A; Mathey D; Bleifeld W
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1384-8. PubMed ID: 7449634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
    Rubin SA; Chatterjee K; Gelberg HJ; Ports TA; Brundage BH; Parmley WW
    Am J Cardiol; 1979 Apr; 43(4):810-5. PubMed ID: 425918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of sustained treatment with prazosin and metoprolol, alone and in combination, in borderline hypertensive heart failure.
    Nelson GI; Donnelly GL; Hunyor SN
    J Cardiovasc Pharmacol; 1982; 4(2):240-5. PubMed ID: 6175807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prazosin in the treatment of severe chronic congestive cardiac failure.
    Hockings BE; Cope GD; Clarke GM; Taylor RR
    Aust N Z J Med; 1980 Aug; 10(4):420-5. PubMed ID: 6932833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of prazosin in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI; Comşulea L; Streian C
    Med Interne; 1984; 22(1):29-33. PubMed ID: 6710045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of vasodilator drug prazosin with digoxin in aortic regurgitation.
    Hockings BE; Cope GD; Clarke GM; Taylor RR
    Br Heart J; 1980 May; 43(5):550-5. PubMed ID: 7378215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.